EMA发布QRD附录V第36版:各国不良反应报告系统详情(EMA/67830/2013)
QRD Appendix V - Adverse-drug-reaction reporting details
EMA于2026年10月27日发布QRD附录V第36版(EMA/67830/2013),列出各成员国国家不良反应报告系统的具体联系方式,供SmPC第4.8节和包装说明书第4节使用。附录明确印刷包装材料不得引用附录V本身,只能显示相关成员国的实际报告系统详情。

27 October 2026
EMA/67830/2013,Version 361
Human Medicines Division
APPENDIX V
List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 “Undesirable effects” of SmPC and section 4 “Possible side effects” of package leaflet.
No reference to the Appendix V should be included in the printed packaging materials. Only the actual details of the national reporting system (as listed within this Appendix V) of the concerned Member State(s) shall be displayed on the printed version.
Bracketing convention:
[text]: For guidance only. This text should not be included on the printed packaging materials.
België/Belgique/Belgien
[Dutch]
Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten
Afdeling Vigilantie:
Website: www.eenbijwerkingmelden.be
e-mail: adr@fagg-afmps.be
[French]
Agence fédérale des médicaments et des produits de santé
Division Vigilance:
Site internet: www.notifieruneffetindesirable.be
e-mail: adr@fagg-afmps.be
[German]
Föderalagentur für Arzneimittel und Gesundheitsprodukte
Abteilung Vigilanz:
Website: www.notifieruneffetindesirable.be
e-mail: adr@fagg-afmps.beLietuva
Valstybinė vaistų kontrolės tarnyba prie Lietuvos Respublikos sveikatos apsaugos ministerijos
Tel.: +370 800 73 568
Informacija pranešimo formos pildymui ir pateikimui: https://vvkt.lrv.lt/lt/ България
Изпълнителна агенция по лекарствата
ул. „Дамян Груев“ № 8
1303 София
Te л.: +359 2 8903417
уебсайт:www.bda.bgLuxembourg/Luxemburg
[French]
Centre Régional de Pharmacovigilance de Nancy ou Division de la pharmacie et des médicaments de la Direction de la santé
Site internet : www.guichet.lu/pharmacovigilance
[German]
Centre Régional de Pharmacovigilance de Nancy oder Abteilung Pharmazie und Medikamente (Division de la pharmacie et des médicaments) der Gesundheitsbehörde in Luxemburg
Website : www.guichet.lu/pharmakovigilanz Česko
webového formulářesukl.gov.cz/nezadouciucinky
případně na adresu:
Státní ústav pro kontrolu léčiv
Šrobárova 49/48
100 00 Praha 10
email: farmakovigilance@sukl.gov.czMagyarország
Nemzeti Népegészségügyi és
Gyógyszerészeti Központ
Postafiók 450
H-1372 Budapest
Honlap: www.nngyk.gov.hu
elektronikus úton történő mellékhatás-bejelentés: https://mellekhatas.nngyk.gov.hu
e-mail: adr.box@nngyk.gov.hu Danmark
Lægemiddelstyrelsen
Axel Heides Gade 1
DK-2300 København S
Websted: www.meldenbivirkning.dkMalta
ADR Reporting Website: https://medicinesauthority.gov.mt/adrportal Deutschland
Bundesinstitut für Arzneimittel und Medizinprodukte
Abt. Pharmakovigilanz
Kurt-Georg-Kiesinger-Allee 3
D-53175 Bonn
Website: http://www.bfarm.de
[For vaccines/biological medicinal products]
Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
Paul-Ehrlich-Institut
Paul-Ehrlich-Str. 51-59
63225 Langen
Tel: +49 6103 77 0
Fax: +49 6103 77 1234
Website:www.pei.deNederland
Nederlands Bijwerkingen Centrum Lareb
Website:www.lareb.nl Eesti
Ravimiamet
Koduleht: www.ravimiamet.ee**Norge**
Direktoratet for medisinske produkter
[For SmPC]
Nettside: www.dmp.no/meldeskjema
[For package leaflet]
Nettside: www.dmp.no/pasientmelding Ελλάδα
Εθνικός Οργανισμός Φαρμάκων
Μεσογείων 284
GR-15562 Χολαργός, Αθήνα
Τηλ: + 30 21 32040337
Ιστότοπος: http://www.eof.gr
http://www.kitrinikarta.grÖsterreich
Bundesamt für Sicherheit im Gesundheitswesen
Traisengasse 5
1200 WIEN
ÖSTERREICH
Fax: + 43 (0) 50 555 36207
Website: http://www.basg.gv.at/ España
Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: www.notificaRAM.esPolska
Departament Monitorowania Niepożądanych Działań Produktów Leczniczych Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych
Al. Jerozolimskie 181C
02-222 Warszawa
Tel.: + 48 22 49 21 301
Faks: + 48 22 49 21 309
Strona internetowa:https://smz.ezdrowie.gov.pl France
Agence nationale de sécurité du médicament et des produits de santé (ANSM)
et réseau des Centres Régionaux de Pharmacovigilance
Site internet:https://signalement.social-sante.gouv.fr/Portugal
Sítio da internet: http://www.infarmed.pt/web/infarmed/submissaoram
(preferencialmente)
ou através dos seguintes contactos:
Direção de Gestão do Risco de Medicamentos
Parque da Saúde de Lisboa, Av. Brasil 53
1749-004 Lisboa
Tel: +351 21 798 73 73
Linha do Medicamento: 800222444 (gratuita)
e-mail: farmacovigilancia@infarmed.pt Hrvatska
Agencija za lijekove i medicinske proizvode (HALMED)
Internetska stranica: www.halmed.hrRomânia
Agenţia Naţională a Medicamentului şi a Dispozitivelor Medicale din România
Str. Aviator Sănătescu nr. 48, sector 1
Bucure ş ti 011478- RO
e-mail: adr@anm.ro
Website: www.anm.ro Ireland
HPRA Pharmacovigilance
Website: www.hpra.ieSlovenija
Javna agencija Republike Slovenije za zdravila in medicinske pripomočke
Sektor za farmakovigilanco
Nacionalni center za farmakovigilanco
Slovenčeva ulica 22
SI-1000 Ljubljana
Tel: +386 (0)8 2000 500
Faks: +386 (0)8 2000 510
e-pošta: h-farmakovigilanca@jazmp.si
spletna stran: www.jazmp.si
Ísland
til Lyfjastofnunar,www.lyfjastofnun.isSlovenská republika
Štátny ústav pre kontrolu liečiv
Sekcia vigilancie
Kvetná 11
SK-825 08 Bratislava
Tel: + 421 2 507 01 206
e-mail:neziaduce.ucinky@sukl.sk
Tla č ivo na hlásenie podozrenia na ne ž iaduci ú č inok lieku je na webovej stránke www.sukl.sk v č asti Nežiaduce účinky liekov
Formulár na elektronické podávanie hlásení: https://portal.sukl.sk/eskadra/ Italia
Agenzia Italiana del Farmaco
Sito web:
https://www.aifa.gov.it/content/segnalazioni-reazioni-avverseSuomi/Finland
[Finnish]
www-sivusto: www.fimea.fi
Lääkealan turvallisuus- ja kehittämiskeskus Fimea
Lääkkeiden haittavaikutusrekisteri
PL 55
00034 FIMEA
[Swedish]
webbplats: www.fimea.fi
Säkerhets- och utvecklingscentret för läkemedelsområdet Fimea
Biverkningsregistret
PB 55
00034 FIMEA Κύπρος
Φαρμακευτικές Υπηρεσίες
Υπουργείο Υγείας
CY-1475 Λευκωσία
Τηλ: +357 22608607
Φαξ: + 357 22608669
Ιστότοπος: www.moh.gov.cy/phsSverige
Läkemedelsverket
Box 26
751 03 Uppsala
Webbplats:www.lakemedelsverket.se Latvija
Zāļu valsts aģentūra
Jersikas iela 15
Rīga, LV 1003
Tīmekļa vietne: www.zva.gov.lvUnited Kingdom (Northern Ireland)*
Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcardor search for MHRA Yellow Card in the Google Play or Apple App Store
[for COVID-19 products/treatments]
Yellow Card Scheme
Website: https://coronavirus-yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store
- Not applicable to centrally authorised medicinal products
1 Changes implemented in the different revisions:
V.34: LT details updated (16 December 2025)
V.35: PL and CZ details updated (20 March 2026)
V.36: SK details updated (27 October 2026)
For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI, also referred to as the Windsor Framework.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands An agency of the European Union
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a questionGo to www.ema.europa.eu/contact**Telephone** +31 (0)88 781 6000
© European Medicines Agency, 2026. Reproduction is authorised provided the source is acknowledged.
来源:EMA Inspections · ema.europa.eu